Wrap Text
Result of AGM
Assura plc
(Incorporated in England and Wales)
(Company Number: 09349441)
LEI number: 21380026T19N2Y52XF72
LSE Share Code: AGR
JSE Share Code: AHR
ISIN Code: GB00BVGBWW93
("Assura" or the "Company")
Result of AGM
Following its annual general meeting ("AGM") held today, Assura announces the results of the
poll vote for each of the resolutions submitted to the meeting (as set out in the Notice of the
AGM dated 5 September 2025). All resolutions except for resolutions 13 to 16 were passed
as Primary Health Properties PLC decided they were not required at the current time.
Total Votes
Cast (% of
% % issued share Votes
Resolution For For Against Against capital) Withheld
1. To receive the
Company's annual 3,193,912,732
report and accounts 3,191,210,029 99.92 2,702,703 0.08 (98.08) 24,556
2. To approve the
Directors' 3,193,912,732
Remuneration Policy 3,191,198,870 99.92 2,713,862 0.08 (98.08) 24,556
3. To approve the
Directors' 3,193,911,679
Remuneration Report 3,191,196,870 99.92 2,714,809 0.08 (98.08) 25,609
4. To re-appoint Ernst
& Young LLP as 3,193,912,732
auditor of the Company 3,191,210,029 99.92 2,702,703 0.08 (98.08) 24,556
5. To authorise the
Audit Committee to
determine the auditor's 3,193,912,732
remuneration 3,191,210,029 99.92 2,702,703 0.08 (98.08) 24,556
6. To re-elect Jonathan
Murphy as a Director of 3,193,912,732
the Company 3,191,208,029 99.92 2,704,703 0.08 (98.08) 24,556
7. To re-elect Jayne
Cottam as a Director of 3,193,912,732
the Company 3,191,208,029 99.92 2,704,703 0.08 (98.08) 24,556
8. To re-elect Louise
Fowler as a Director of 3,193,912,732
the Company 3,190,442,909 99.89 3,469,823 0.11 (98.08) 24,556
9. To re-elect Jonathan
Davies as a Director of 3,193,912,732
the Company 3,189,424,843 99.86 4,487,889 0.14 (98.08) 24,556
10. To re-elect
Samantha Barrell as a
Director of the 3,193,912,732
Company 3,190,440,909 99.89 3,471,823 0.11 (98.08) 24,556
11. To re-elect Emma
Cariaga as a Director 3,193,912,732
of the Company 3,191,210,029 99.92 2,702,703 0.08 (98.08) 24,556
12. To re-elect Noel
Gordon as a Director of 3,193,912,732
the Company 3,191,185,999 99.91 2,726,733 0.09 (98.08) 24,556
13. To authorise the 3,193,911,679
Directors to allot shares 24,777,490 0.78 3,169,134,189 99.22 (98.08) 25,609
14. To authorise the
Directors to disapply 3,193,912,632
pre-emption rights 13,632,718 0.43 3,180,279,914 99.57 (98.08) 24,656
15. To authorise the
Directors to disapply
pre-emption rights in
connection with an
acquisition or specified 3,193,911,579
capital investment 12,529,192 0.39 3,181,382,387 99.61 (98.08) 25,709
16. To authorise the
market purchase of the 3,193,912,732
Company's own shares 25,792,609 0.81 3,168,120,123 99.19 (98.08) 24,556
17. To authorise re-
registration of the
Company as a private
company and adopt
new articles of 3,193,912,732
association 3,191,208,029 99.92 2,704,703 0.08 (98.08) 24,556
18. To authorise the
Company to call any
general meeting, other
than an annual general
meeting, by not less
than 14 clear days' 3,193,912,732
notice 3,190,267,614 99.89 3,645,118 0.11 (98.08) 24,556
Resolutions 1 to 12 were passed as ordinary resolutions. Resolutions 17 and 18 were passed
as special resolutions. Votes 'For' include votes at the discretion of the Chairman.
Notes:
1. The percentages above are rounded to two decimal places.
2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of
votes "For" and "Against" a resolution.
3. The total number of Assura ordinary shares in issue as at 6.00 pm on 26 September 2025,
the time by which shareholders who wanted to vote at the AGM must have been entered on
the Company's register of members, was 3,256,393,191 and the total number of voting rights
in the Company was also 3,256,393,191.
Copies of resolutions 17 and 18, being resolutions other than resolutions concerning ordinary
business passed by the Company at the above AGM, have been submitted to the National
Storage Mechanism and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
- Ends -
For more information, please contact:
Assura plc Tel: 0161 515 2043
Orla Ball, General Counsel Email: Investor@assura.co.uk
David Purcell, Investor Relations Director
FGS Global Tel: 0207 251 3801
Gordon Simpson Email: Assura-LON@fgsglobal.com
Grace Whelan
Notes to Editors
Assura is the UK's leading diversified healthcare REIT. Assura enables better health outcomes
through its portfolio of more than 600 healthcare buildings, from which over six million patients
are served.
A UK REIT based in Altrincham, Assura is currently a constituent of the EPRA* index and has
a secondary listing on the Johannesburg Stock Exchange. As at 31 March 2025, Assura's
portfolio was valued at £3.1 billion and has a strong track record of growing financial returns
and dividends for shareholders.
At Assura we BUILD for health and as a certified B Corp we are committed to keeping ESG
as the heart of our strategy, creating Healthy Environments (E), Healthy Communities (S) and
maintaining a Healthy Business (G).
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.
30 September 2025
JSE Sponsor
Nedbank Corporate and Investment Banking, a division of Nedbank Limited
Date: 30-09-2025 04:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
